狂犬病診断薬の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

狂犬病診断薬市場の世界需要は、2022年の45億6,000万米ドルから2030年には80億5,000万米ドル近くの市場規模に達すると推定され、調査期間2023年～2030年のCAGRは6.52%です。

狂犬病は急性ウイルス感染症であり、通常は神経系に感染します。狂犬病の原因物質はラブドウイルスであり、一般に狂犬病に罹患した動物に咬まれることで感染します。最も一般的に知られている狂犬病診断法には、蛍光抗体検査（FAT）、免疫組織化学検査、直接蛍光抗体（DFA）検査、増幅法などがあります。直接蛍光抗体（DFA）検査は動物の狂犬病診断に使用でき、脳組織中の狂犬病ウイルス抗原の存在を見つけることができます。しかし、ヒトに対しては複数の検査が必要です。

市場力学：

顧みられない熱帯病（NTDs）の流行の増加は、狂犬病診断薬市場の成長率を押し上げる重要な要因です。さらに、犬に咬まれる事例が増加するにつれて狂犬病の罹患率も上昇し、これが市場の成長率を押し上げると思われます。狂犬病診断に関連する法律の増加は、市場の成長に寄与する重要な要因です。また、ヘルスケア支出の増加や、ウイルス感染による致死率に関する国民の意識が、市場成長を支える主な要因となっています。さらに、新製品創出のための組織間連携の拡大や狂犬病研究の開拓は、狂犬病診断薬市場の発展に好影響を与えるであろう。狂犬病治療および診断ソリューションへの先端技術の採用が世界的に増加していることも、狂犬病診断薬市場の成長を促進する主要因です。

本調査レポートでは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を取り上げています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは狂犬病診断薬の世界市場における各セグメントを包括的に評価することもできます。狂犬病診断薬業界の成長と動向は、本調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける狂犬病診断薬市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

• 市場のハイライト
• 世界市場スナップショット

第3章 狂犬病診断薬-産業分析

• イントロダクション：市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 業界動向
• ポーターのファイブフォース分析
• 市場魅力度分析

第4章 バリューチェーン分析

• バリューチェーン分析
• 原材料分析
  • 原材料リスト
  • 原材料メーカーリスト
  • 主要原材料の価格動向
• 潜在的バイヤーのリスト
• マーケティングチャネル
  • ダイレクトマーケティング
  • インダイレクトマーケティング
  • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 狂犬病診断薬の世界市場分析：診断方法別

• 診断方法別の概要
• 実績データと予測データ
• 診断方法別分析
• 蛍光抗体検査（FAT）
• 免疫組織化学検査
• 増幅法
• 組織学的検査
• 血清学的検査

第7章 狂犬病診断薬の世界市場分析：技術手法別

• 技術手法別概要
• 実績データと予測データ
• 技術手法別分析
• ELISA/免疫組織化学法
• クロマトグラフィー技術
• PCR法
• その他

第8章 狂犬病診断薬の世界市場分析：地域別

• 地域別展望
• イントロダクション
• 北米売上分析
  • 概要、実績と予測
  • 北米：セグメント別
  • 北米：国別
  • 米国
  • カナダ
  • メキシコ
• 欧州売上分析
  • 概要、実績と予測
  • 欧州：セグメント別
  • 欧州：国別
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋売上分析
  • 概要、実績と予測
  • アジア太平洋：セグメント別
  • アジア太平洋：国別
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
  • その他アジア太平洋
• ラテンアメリカ売上分析
  • 概要、実績と予測
  • ラテンアメリカ：セグメント別
  • ラテンアメリカ：国別
  • ブラジル
  • アルゼンチン
  • ペルー
  • チリ
  • その他ラテンアメリカ
• 中東・アフリカ売上分析
  • 概要、実績と予測
  • 中東・アフリカ：セグメント別
  • 中東・アフリカ：国別
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東とアフリカ

第9章 狂犬病診断薬企業の競合情勢

• 狂犬病診断薬市場の競合
• パートナーシップ/提携/合意
• 合併・買収
• 新製品の上市
• その他の開発

第10章 企業プロファイル

• 上位企業の市場シェア分析
• 市場集中度
• Bio-Rad Laboratories Inc.
• Aviva Systems Biology Corporation
• Merck KGaA
• Demeditec Diagnostics GmbH
• Creative Diagnostics
• Norgen Biotek Corp.
• Abbexa Ltd.
• Express Biotech International Inc.
• BioNote Inc.
• MyBioSource.com.

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Diagnostic Method (USD MN)
• Fluorescent Antibody Test (FAT) Market Sales by Geography (USD MN)
• Immunohistochemical Test Market Sales by Geography (USD MN)
• Amplification Methods Market Sales by Geography (USD MN)
• Histologic Examination Market Sales by Geography (USD MN)
• Serology Tests Market Sales by Geography (USD MN)
• Analysis Market by Technology Method (USD MN)
• ELISA/Immunohistochemistry Market Sales by Geography (USD MN)
• Chromatography Techniques Market Sales by Geography (USD MN)
• PCR Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Rabies Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Rabies Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Rabies Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Diagnostic Method
• Market Attractiveness Analysis by Technology Method
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Diagnostic Method (USD MN)
• Fluorescent Antibody Test (FAT) Market Sales by Geography (USD MN)
• Immunohistochemical Test Market Sales by Geography (USD MN)
• Amplification Methods Market Sales by Geography (USD MN)
• Histologic Examination Market Sales by Geography (USD MN)
• Serology Tests Market Sales by Geography (USD MN)
• Global Market Analysis by Technology Method (USD MN)
• ELISA/Immunohistochemistry Market Sales by Geography (USD MN)
• Chromatography Techniques Market Sales by Geography (USD MN)
• PCR Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

The global demand for Rabies Diagnostics Market is presumed to reach the market size of nearly USD 8.05 BN by 2030 from USD 4.56 BN in 2022 with a CAGR of 6.52% under the study period 2023 - 2030.

Rabies is an acute viral infection that typically infects the neurological system. The causative agent of rabies is rhabdovirus, which is generally spread via the bite of a rabid animal. The most popularly known rabies diagnostic methods include Fluorescent Antibody Test (FAT), immunohistochemical tests, Direct Fluorescent Antibody (DFA) tests, and amplification methods. A direct fluorescent antibody (DFA) test can be used to diagnose rabies in animals and can find the presence of rabies viral antigens in brain tissue. However, several tests are necessary for humans.

MARKET DYNAMICS:

The increasing prevalence of neglected tropical diseases (NTDs) will be a crucial factor in boosting the growth rate of the rabies diagnostics market. Furthermore, the incidences of rabies will rise as dog bite instances rise, which will positively drive the market's growth rate. The increase in laws related to rabies diagnosis is a crucial factor contributing to the market's growth. In addition, rising healthcare expenditure and public awareness regarding the fatality of viral exposure are the main factors that will support market growth. Additionally, the expansion of organization-to-organization collaborations for the creation of novel products and the development of rabies research will favorably influence the development of the rabies diagnostics market. The increasing adoption of advanced technology for rabies care and diagnostic solutions worldwide is another major factor propelling the market growth for rabies diagnostics.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of rabies diagnostics. The growth and trends of rabies diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the rabies diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Diagnostic Method

• Fluorescent Antibody Test (FAT)
• Immunohistochemical Test
• Amplification Methods
• Histologic Examination
• Serology Tests

By Technology Method

• ELISA/Immunohistochemistry
• Chromatography Techniques
• PCR
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Rabies Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the rabies diagnostics market include Bio-Rad Laboratories Inc., Aviva Systems Biology Corporation, Merck KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, Norgen Biotek Corp., Abbexa Ltd., Express Biotech International Inc., BioNote Inc., MyBioSource.com. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . RABIES DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Diagnostic Method
  • 3.7.2 Market Attractiveness Analysis By Technology Method
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY DIAGNOSTIC METHOD

• 6.1 Overview by Diagnostic Method
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Diagnostic Method
• 6.4 Fluorescent Antibody Test (FAT) Historic and Forecast Sales by Regions
• 6.5 Immunohistochemical Test Historic and Forecast Sales by Regions
• 6.6 Amplification Methods Historic and Forecast Sales by Regions
• 6.7 Histologic Examination Historic and Forecast Sales by Regions
• 6.8 Serology Tests Historic and Forecast Sales by Regions

7 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY METHOD

• 7.1 Overview by Technology Method
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Technology Method
• 7.4 ELISA/Immunohistochemistry Historic and Forecast Sales by Regions
• 7.5 Chromatography Techniques Historic and Forecast Sales by Regions
• 7.6 PCR Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL RABIES DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RABIES DIAGNOSTICS COMPANIES

• 9.1. Rabies Diagnostics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF RABIES DIAGNOSTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Bio-Rad Laboratories Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Aviva Systems Biology Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Merck KGaA
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Demeditec Diagnostics GmbH
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Creative Diagnostics
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Norgen Biotek Corp.
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. Abbexa Ltd.
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. Express Biotech International Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. BioNote Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. MyBioSource.com.
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies